Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.

Read more
Colli Pee Novosanis

Sampling solutions

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Learn more

Delivery solutions

Improving intradermal drug delivery by highly accurate injection of small volumes in the skin

Learn more

Latest news

View all news

Colli-Pee® Variants

Novosanis launches volume variants of Colli-Pee® offering new applications in urine testing

8/10/2019
We are excited to announce the launch of volume variants of Colli-Pee® , our innovative urine-capturing device offering additional applications in the fields of infectious disease, uro-oncology and more.
Read more

Latest blogpost

View all blogs

Towards a world without STIs – Urine sampling offers easy and efficient collection and is a more preferred testing method

Towards a world without STIs – Urine sampling offers easy and efficient collection and is a more preferred testing method

15/11/2019
Urine has great potential in improving detection of several sexually transmitted infections (STIs). Read more about latest research in our blog.
Read more

Upcoming event

View all events

ESOU20

ESOU20

Dublin
Novosanis will be attending the 17th Meeting of the EAU Section of Oncological Urology in Dublin from 17 to 19 January 2020.
Read more
Events
View all events
Regulatory
Certificates
Team
View all team members
News
View all news